Publication | Closed Access

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Advanced Ovarian CancerMedicineMetronomic TherapyPharmacologyDose-dense PaclitaxelGynecologyPharmacotherapyCancer TreatmentOncologyGynecology OncologyPhase 3Ovarian Cancer